Overview

Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine the pharmacokinetics of favipiravir in volunteers with hepatic impairment and in healthy control volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
MDVI, LLC
Treatments:
Favipiravir